TY - JOUR
T1 - Nanoprobing of the effect of Cu2+ cations on misfolding, interaction and aggregation of amyloid β peptide
AU - Lv, Zhengjian
AU - Condron, Margaret M.
AU - Teplow, David B.
AU - Lyubchenko, Yuri L.
N1 - Funding Information:
Acknowledgments We thank A. Krasnoslobodtsev, A. Portillo, Zenghan Tong, Yuliang Zhang and other group members for insightful suggestions and discussions. The work was supported by grants to Y.L.L. from the National Institutes of Health (NIH: GM096039), U.S. Department of Energy Grant DE-FG02-08ER64579, the Nebraska Research Initiative and grants to D.B.T. from NIH (NS038328, AG041295) and the Jim Easton Consortium for Drug Development and Biomarkers.
PY - 2013/3
Y1 - 2013/3
N2 - Misfolding and aggregation of the amyloid β-protein (Aβ) are hallmarks of Alzheimer's disease. Both processes are dependent on the environmental conditions, including the presence of divalent cations, such as Cu2+. Cu2+ cations regulate early stages of Aβ aggregation, but the molecular mechanism of Cu2+ regulation is unknown. In this study we applied single molecule AFM force spectroscopy to elucidate the role of Cu2+ cations on interpeptide interactions. By immobilizing one of two interacting Aβ42 molecules on a mica surface and tethering the counterpart molecule onto the tip, we were able to probe the interpeptide interactions in the presence and absence of Cu2+ cations at pH 7.4, 6.8, 6.0, 5.0, and 4.0. The results show that the presence of Cu2+ cations change the pattern of Aβ interactions for pH values between pH 7.4 and pH 5.0. Under these conditions, Cu2+ cations induce Aβ42 peptide structural changes resulting in N-termini interactions within the dimers. Cu2+ cations also stabilize the dimers. No effects of Cu2+ cations on Aβ-Aβ interactions were observed at pH 4.0, suggesting that peptide protonation changes the peptide-cation interaction. The effect of Cu2+ cations on later stages of Aβ aggregation was studied by AFM topographic images. The results demonstrate that substoichiometric Cu2+ cations accelerate the formation of fibrils at pH 7.4 and 5.0, whereas no effect of Cu2+ cations was observed at pH 4.0. Taken together, the combined AFM force spectroscopy and imaging analyses demonstrate that Cu2+ cations promote both the initial and the elongation stages of Aβ aggregation, but protein protonation diminishes the effect of Cu2+.
AB - Misfolding and aggregation of the amyloid β-protein (Aβ) are hallmarks of Alzheimer's disease. Both processes are dependent on the environmental conditions, including the presence of divalent cations, such as Cu2+. Cu2+ cations regulate early stages of Aβ aggregation, but the molecular mechanism of Cu2+ regulation is unknown. In this study we applied single molecule AFM force spectroscopy to elucidate the role of Cu2+ cations on interpeptide interactions. By immobilizing one of two interacting Aβ42 molecules on a mica surface and tethering the counterpart molecule onto the tip, we were able to probe the interpeptide interactions in the presence and absence of Cu2+ cations at pH 7.4, 6.8, 6.0, 5.0, and 4.0. The results show that the presence of Cu2+ cations change the pattern of Aβ interactions for pH values between pH 7.4 and pH 5.0. Under these conditions, Cu2+ cations induce Aβ42 peptide structural changes resulting in N-termini interactions within the dimers. Cu2+ cations also stabilize the dimers. No effects of Cu2+ cations on Aβ-Aβ interactions were observed at pH 4.0, suggesting that peptide protonation changes the peptide-cation interaction. The effect of Cu2+ cations on later stages of Aβ aggregation was studied by AFM topographic images. The results demonstrate that substoichiometric Cu2+ cations accelerate the formation of fibrils at pH 7.4 and 5.0, whereas no effect of Cu2+ cations was observed at pH 4.0. Taken together, the combined AFM force spectroscopy and imaging analyses demonstrate that Cu2+ cations promote both the initial and the elongation stages of Aβ aggregation, but protein protonation diminishes the effect of Cu2+.
KW - Alzheimer's disease
KW - Amyloid β-protein, Aβ42
KW - Atomic force microscopy imaging
KW - Cu cations
KW - Single molecule force spectroscopy
UR - http://www.scopus.com/inward/record.url?scp=84874652160&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84874652160&partnerID=8YFLogxK
U2 - 10.1007/s11481-012-9416-6
DO - 10.1007/s11481-012-9416-6
M3 - Article
C2 - 23143330
AN - SCOPUS:84874652160
SN - 1557-1890
VL - 8
SP - 262
EP - 273
JO - Journal of NeuroImmune Pharmacology
JF - Journal of NeuroImmune Pharmacology
IS - 1
ER -